Pretax income is the income that a company earns before paying income taxes. TransMedics Group's pretax income for the
three
months ended in Dec. 2023 was $3.9 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was $-26.7 Mil.
TransMedics Group's pretax margin was 4.76%.
During the past 8 years, TransMedics Group's highest Pretax Margin was -11.04%. The lowest was -387.58%. And the median was -143.97%.
TransMedics Group Pre-Tax Income Historical Data
The historical data trend for TransMedics Group's Pre-Tax Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of TransMedics Group's Pre-Tax Income
For the Medical Devices subindustry, TransMedics Group's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TransMedics Group's Pre-Tax Income Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, TransMedics Group's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where TransMedics Group's Pre-Tax Income falls into.
TransMedics Group Pre-Tax Income Calculation
This is the income that a company earns before paying income taxes.
TransMedics Group's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as
Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-26.7 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TransMedics Group (NAS:TMDX) Pre-Tax Income Explanation
TransMedics Group's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as
During the past 8 years, TransMedics Group's highest Pretax Margin was -11.04%. The lowest was -387.58%. And the median was -143.97%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TransMedics Group Pre-Tax Income Related Terms
Thank you for viewing the detailed overview of TransMedics Group's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.
TransMedics Group (TransMedics Group) Business Description
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TMDX has been successfully added to your 